Erythropoietin in patients with acute myocardial infarction: No proof of effectiveness or proof of no effectiveness?

Clinical Cardiology

Volumn 36, Issue 10, 2013, Pages

  Messori, Andrea ^a   Fadda, Valeria ^a   Maratea, Dario ^a   Trippoli, Sabrina ^a  

^a ESTAV Toscana Centro   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PLACEBO;

ACUTE HEART INFARCTION; DRUG EFFICACY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LETTER; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; DATA INTERPRETATION, STATISTICAL; ERYTHROPOIETIN; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDIAL INFARCTION; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84885468181     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22187     Document Type: Letter

References (5)

1. Gao D, Ning N, Niu X, et al. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials. Am Heart J. 2012; 164: 715-727.
2. Minamino T, Toba K, Higo S, et al. EPO-AMI-II Study Investigators. Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trial. Cardiovasc Drugs Ther. 2012; 26: 409-416.
3. Wetterslev J, Thorlund K, Brok J, et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008; 61: 64-75.
4. Maratea D, Fadda V, Trippoli S, et al. Off-pump versus on-pump coronary artery bypass grafting: quantifying information size by trial sequential analysis [published online ahead of print May 20, 2013]. Eur J Intern Med. doi: 10.1016/j.ejim.2013.04.011.
5. Messori A, Fadda V, Maratea D, et al. Same-day discharge after percutaneous coronary intervention: trial sequential analysis of outcomes. J Am Coll Cardiol. In press.